Clinical trial
Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
NCT00002707 · NSABP Foundation Inc, Other · Completed
Key facts
| NCT number | NCT00002707 |
|---|---|
| Title | Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed |
| Official title | A RANDOMIZED TRIAL COMPARING PREOPERATIVE DOXORUBICIN (ADRIAMYCIN)/CYCLOPHOSPHAMIDE (AC) TO PREOPERATIVE AC FOLLOWED BY PREOPERATIVE DOCETAXEL (TAXOTERE) AND TO PREOPERATIVE AC FOLLOWED BY POSTOPERATIVE DOCETAXEL IN PATIENTS WITH OPERABLE CARCINOMA OF THE BREAST |
| Lead sponsor | NSABP Foundation Inc, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Cyclophosphamide, Docetaxel, Doxorubicin, Tamoxifen |
| Enrollment | 2,411 |
| Start date | Dec 1, 1995 |
| Primary completion | Jun 1, 2002 |
| Completion | Feb 1, 2010 |
| First posted | May 21, 2004 |
| Last update posted | Feb 3, 2010 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: